Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
07. Januar 2025 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate...
Repligen Launches the CTech™ SoloVPE® PLUS System
06. Januar 2025 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of...
Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report
12. Dezember 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication...
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns
09. Dezember 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of AVIPure®...
Repligen Reports Third Quarter 2024 Financial Results
12. November 2024 07:30 ET
|
Repligen Corporation
Q3 2024 Earnings Report
Repligen Corporation to Present at Upcoming Investor Conferences
05. November 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be...
Repligen to Report Third Quarter 2024 Financial Results
31. Oktober 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2024 financial results on Tuesday, November 12,...
Repligen Opens Training & Innovation Center to Elevate Customer Experience
24. September 2024 07:30 ET
|
Repligen Corporation
Repligen opens Training and Innovation Center (RTIC) to support biopharma and CDMO customer experience with the company's bioprocessing technologies.
Repligen Corporation to Present at Wells Fargo Healthcare Conference
23. August 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be...
Repligen Reports Second Quarter 2024 Financial Results
30. Juli 2024 07:30 ET
|
Repligen Corporation
Reports second quarter revenue of $154 millionSecond quarter orders of $157 millionBook-to-bill 1.02 for the quarter, 1.01 year-to-dateAchieved first half revenue and order targetsNarrows revenue...